Giant cell myocarditis after first dose of BNT162b2 – a case report

View Full Paper

Ask AI

Bookmark

Population

A young man presenting with shortness of breath and elevated troponin

Comparison

First dose of BNT162b2 vaccine

Design

Case report

Authors

Discussion

Should not alter vaccination practice; leaves open causality and remains hypothesis-generating.

Population

A young man presenting with shortness of breath and elevated troponin

Intervention

First dose of BNT162b2 mRNA vaccine

Outcome

Giant cell myocarditissafety

This case report highlights a rare occurrence of giant cell myocarditis following administration of the BNT162b2 mRNA vaccine.

Hirsch et al. (2022) studied this question.

View Full Paper

Ask AI

Bookmark